Abstract:Background Non-alcoholic fatty pancreas disease (NAFPD) can be detected using various imaging techniques, but accurately measuring the amount of fat in the pancreas remains difficult. Fatty acid binding protein-1 (FABP-1) is a marker specific to certain tissues and can aid in diagnosing NAFPD. However, this study aimed to investigate the prevalence of NAFPD among obese and non-obese people with and without diabetes mellitus (DM). Additionally, it aimed to evaluate the associated risk factors for NAFPD and the utility of the FABP-1 level as a simple, non-invasive biomarker for diagnosing NAFPD. Methods This study is a prospective cross-sectional study. Results Ninety-five patients were enrolled in the study, comprising 35 males and 60 females, with a mean age of 44 years and a standard deviation (SD) of 11 years. However, 26.3 % were morbidly obese, 22.1 % were severely obese, 31.6 % were obese, 12.6 % were overweight, and 7.4 % were normal. Additionally, 35.8 % had diabetes mellitus, while 26.3 % of patients had hypertension. Regarding the ultrasonographic findings, 94.7 % of the patients had fatty liver, with the majority (41.1 %) classified as grade II, followed by 38.9 % classified as grade I, and 14.7 % classified as grade III fatty liver. Among these patients, 78.9 % had fatty pancreas, with 38.9 % classified as grade II, 31.6 % classified as grade I, and 8.4 % classified as grade III fatty pancreas. The median FABP-1 level among patients with fatty pancreas was 3.3 ng/ml, which exhibited a significant fair negative correlation with total bilirubin and a fair, positive correlation with alkaline phosphatase and portal vein diameter. A statistically substantial distinction was observed between the levels of AFABP-1 and the presence or grading of the fatty pancreas (p-value = 0.048 and < 0.001, respectively). Using multivariate analysis, FABP-1 was the only significant predictor of a fatty pancreas. The receiver operating characteristic (ROC) curve analysis indicated that at a cut-off point of FABP-1 of ≤ 3.7, it had a sensitivity of 58 %, specificity of 80 %, positive predictive value (PPV) of 96.6 %, negative predictive value (NPV) of 17 %, and an area under the curve (AUC) of 0.77. Conclusion NAFPD is becoming an increasingly significant challenge. FABP-1 can potentially be a straightforward and non-invasive predictor of the fatty pancreas.

A Comprehensive Analysis of a Cohort from the KEDP-Study

Clinical Implications of Plasma Adipocyte Fatty Acid Binding Protein Levels in Patients with Obesity and Type 2 Diabetes

Associations of Serum Adipocyte Fatty Acid Binding Protein with Body Composition and Fat Distribution in Nondiabetic Chinese Women

Postprandial fatty acid-binding protein 4 is associated with muscle insulin resistance

Risk of Gestational Diabetes Mellitus in Relation to Plasma Concentrations of Fatty Acid-Binding Protein 4: A Nested Case-Control Study in China

Cardiometabolic correlates and heritability of fetuin-A, retinol-binding protein 4, and fatty-acid binding protein 4 in the Framingham Heart Study

Multifaced Roles in Reproduction, Pregnancy, and Offspring Health

CORRELATION BETWEEN FATTY BINDING PROTEIN 1 (FABP1) AND DIABETES TYPE 2 (T2DM)

Contribution of a first-degree family history of diabetes to increased serum adipocyte fatty acid binding protein levels independent of body fat content and distribution

Study of non-alcoholic fatty pancreatic disease among the Egyptian population and the value of serum fatty acid binding protein-1 (FABP-1) as a non-invasive biomarker

The Association and Joint Effect of Adipocyte Fatty Acid Binding Protein and Obesity Phenotype with Cardiovascular Events

Circulating Adipocyte Fatty Acid Binding Protein (Fabp4) Levels Are Associated With Irisin In The Middle-Aged General Chinese Population

Associations between circulating levels of FABP4 and TNF receptors are more evident in patients with type 2 diabetes mellitus than in patients with type 1 diabetes mellitus

Serum Fatty Acid-Binding Protein 4 Levels And Responses Of Pancreatic Islet Beta-Cells And Alpha-Cells In Patients With Type 2 Diabetes

Circulating Adipocyte Fatty Acid-Binding Protein Levels Predict the Development of Subclinical Atherosclerosis in Type 2 Diabetes.

Protein Expressions of Plasma Adipocyte Fatty Acid Binding Protein 4 and Phosphatase and Tensin Homolog Deleted on Chromosome Ten and Their Correlation with Insulin Resistance in Patients with Impaired Glucose Regulation and Newly Diagnosed Type 2 Diabete

Serum liver fatty acid binding protein levels correlate positively with obesity and insulin resistance in Chinese young adults.

Serum adipocyte fatty acid binding protein levels in patients with type 2 diabetes mellitus and obesity: the influence of fenofibrate treatment

FABP4 and I-FABP Levels in Pregnant Women Are Associated with Body Mass Index but Not Gestational Diabetes

Serum fatty acid-binding protein 4 levels and responses of pancreatic islet β-cells and α-cells in patients with type 2 diabetes

FABP1 and FABP2 as markers of diabetic nephropathy